NP 13 (Quillichew ER 30 mg)
Generic Name: methylphenidate
Pill imprint NP 13 has been identified as Quillichew ER 30 mg.
QuilliChew ER is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. QuilliChew ER 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Quillichew ER
- Generic Name:
- methylphenidate
- Imprint:
- NP 13
- Strength:
- 30 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Pfizer Inc.
More about QuilliChew ER (methylphenidate)
Consumer resources
- Other brands: Ritalin, Concerta, Quillivant XR, Daytrana, More (7) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
